DE69209414T2 - Hirnaktivitätfördernde Zubereitungen - Google Patents

Hirnaktivitätfördernde Zubereitungen

Info

Publication number
DE69209414T2
DE69209414T2 DE69209414T DE69209414T DE69209414T2 DE 69209414 T2 DE69209414 T2 DE 69209414T2 DE 69209414 T DE69209414 T DE 69209414T DE 69209414 T DE69209414 T DE 69209414T DE 69209414 T2 DE69209414 T2 DE 69209414T2
Authority
DE
Germany
Prior art keywords
preparations
brain activity
promote brain
cerebral performance
alleviation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69209414T
Other languages
German (de)
English (en)
Other versions
DE69209414D1 (de
Inventor
Joachim Bormann
Wolfgang Schatton
Ruediger Koch
Roman Goertelmeyer
Lothar Demisch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merz and Co GmbH and Co KG
Original Assignee
Merz and Co GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz and Co GmbH and Co KG filed Critical Merz and Co GmbH and Co KG
Application granted granted Critical
Publication of DE69209414D1 publication Critical patent/DE69209414D1/de
Publication of DE69209414T2 publication Critical patent/DE69209414T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69209414T 1991-09-06 1992-09-04 Hirnaktivitätfördernde Zubereitungen Expired - Fee Related DE69209414T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/755,814 US5262162A (en) 1991-09-06 1991-09-06 Cerebral-activating extract

Publications (2)

Publication Number Publication Date
DE69209414D1 DE69209414D1 (de) 1996-05-02
DE69209414T2 true DE69209414T2 (de) 1996-12-05

Family

ID=25040758

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69209414T Expired - Fee Related DE69209414T2 (de) 1991-09-06 1992-09-04 Hirnaktivitätfördernde Zubereitungen

Country Status (11)

Country Link
US (1) US5262162A (un)
EP (1) EP0531155B1 (un)
JP (1) JPH05194247A (un)
KR (1) KR100256452B1 (un)
AT (1) ATE135916T1 (un)
CA (1) CA2077589A1 (un)
DE (1) DE69209414T2 (un)
DK (1) DK0531155T3 (un)
ES (1) ES2086666T3 (un)
GR (1) GR3020121T3 (un)
TW (1) TW217989B (un)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004041270A1 (de) * 2004-08-26 2006-03-02 Merz Pharma Gmbh & Co. Kgaa Ein Kapillar- Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE204159T1 (de) * 1995-05-17 2001-09-15 Peter Greither Verfahren zum herstellen eines brausepräparats und brausepräparat
US5747006A (en) * 1997-05-14 1998-05-05 Amway Corporation Skin whitener composition containing acerola cherry fermentate
US5866585A (en) * 1997-05-22 1999-02-02 Synchroneuron, Llc Methods of treating tardive dyskinesia using NMDA receptor antagonists
US6057373A (en) * 1997-05-22 2000-05-02 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
ATE214285T1 (de) * 1997-10-27 2002-03-15 Gergely Gerhard Brausezubereitung mit pflanzenextrakt
US6294583B1 (en) 1998-01-13 2001-09-25 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
US5952389A (en) * 1998-01-13 1999-09-14 Synchroneuron Methods of treating tardive dyskinesia and other movement disorders
EP1052983A2 (en) * 1998-01-27 2000-11-22 Thomas N. Thomas Use of an mao-a or mao-b inhibitor for the treatment of vascular disorders
US6184247B1 (en) 1999-05-21 2001-02-06 Amway Corporation Method of increasing cell renewal rate
US6413558B1 (en) 1999-07-19 2002-07-02 The Proctor & Gamble Co. Compositions, kits, and methods for providing and maintaining energy and metal alertness
PT2608798E (pt) * 2010-08-27 2015-03-26 Finzelberg Gmbh & Co Kg Extractos vegetais de sideritis e sua utilização para aumentar o desempenho cognitivo
JP5788065B2 (ja) * 2013-07-14 2015-09-30 アシロス・エ／エス リベス種から誘導可能な新たな生物活性アルカロイドおよびアルカロイド画分
CN107250340B (zh) 2014-09-16 2021-05-07 罗伯特·布洛西亚 源自基于龙舌兰的烈酒的能量饮品和其他营养辅助物
EP3675890A4 (en) * 2017-08-28 2021-11-03 Vitality Wellness (NZ) Limited IMPROVEMENTS IN IGF-1 ANALYSIS, ADAPTATION AND DISEASE MANAGEMENT IN NON-NEUROLOGICAL AND / OR NEUROLOGICAL DISEASES
EP3886612A4 (en) 2018-11-26 2022-08-17 Roar Holding LLC PROCESSES FOR IMPROVING BEVERAGE QUALITY
US11839622B1 (en) 2020-01-15 2023-12-12 Randall Lewarchik Consumable nutraceutical composition
WO2023163606A1 (en) * 2022-02-28 2023-08-31 Arepa Ip Limited Bioactives and their uses

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR92301E (fr) * 1963-08-09 1968-10-25 Chibret Lab Perfectionnements apportés aux procédés pour l'obtention de glucosides notamment de glucosides d'anthocyanes
FR6760M (un) * 1967-05-30 1969-03-03
ATE24266T1 (de) * 1982-04-16 1987-01-15 Nestle Sa Lipidhaltige zusammensetzung fuer die orale, enterale oder parenterale ernaehrung.
GB2147911B (en) * 1983-10-14 1987-10-07 Nestle Sa A process for the preparation of fatty substances
FR2583640A1 (fr) * 1985-06-24 1986-12-26 Berdal Pascal Compositions pharmaceutiques a visee vasculotrope et antisclereuse
GB2183635B (en) * 1985-10-11 1990-01-24 Peter Jowett Glyceride ester of gamma-linolenic acid
GB8714772D0 (en) * 1987-06-24 1987-07-29 Efamol Ltd Essential fatty acid compositions
FR2622453A1 (fr) * 1987-11-04 1989-05-05 Vaillant Defresne Laboratoire Composition sous forme de gel transparent contenant des grains ou des particules de plantes fraiches ou seches, son procede de preparation et utilisation en cosmetologie, en pharmacie et en hygiene

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004041270A1 (de) * 2004-08-26 2006-03-02 Merz Pharma Gmbh & Co. Kgaa Ein Kapillar- Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung

Also Published As

Publication number Publication date
JPH05194247A (ja) 1993-08-03
ATE135916T1 (de) 1996-04-15
EP0531155A1 (en) 1993-03-10
KR100256452B1 (ko) 2000-05-15
US5262162A (en) 1993-11-16
GR3020121T3 (en) 1996-08-31
TW217989B (un) 1993-12-21
DK0531155T3 (da) 1996-06-10
EP0531155B1 (en) 1996-03-27
CA2077589A1 (en) 1993-03-07
ES2086666T3 (es) 1996-07-01
DE69209414D1 (de) 1996-05-02

Similar Documents

Publication Publication Date Title
DE69209414D1 (de) Hirnaktivitätfördernde Zubereitungen
Barsky Amplification, somatization, and the somatoform disorders.
Turner et al. Depression and disability: The stress process in a chronically strained population.
NO881657D0 (no) Medisinske preparater paa grunnlag av oelmaskekstrakt, fremgangsmaate for fremstilling -derav samt anvendelse av oelmaskekstrakt for fremstilling av kosmetiske preparater og et spesielt oelmaskekstrakt.
WO2002036829A3 (en) Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries
ATE100322T1 (de) Verwendung von uridin zur behandlung nervoeser stoerungen.
SV1998000138A (es) Uso de aminometil-cromanos sustituidos para el impedimento de la degeneracion neuronal y para el estimulo de la regeneracion neuronal ref.lea 32408
Caplan Population-oriented psychiatry.
EP0267676A3 (en) Use of 1,3-di-n-butyl-7-(2-oxypropyl) xanthine in the treatment of cerebrovascular or cerebral senility associated disorders, peripheral vascular disease and proliferative skin diseases
Grandin Brief report: Response to national institutes of health report
ATE113478T1 (de) Verwendung antigener substanzen zur prophylaxe oder therapie von störungen und krankheiten im verdauungstrakt von tieren und menschen.
EP0383171A3 (en) 2,3,23-trihydroxy-urs-12-ene derivatives for treating cognitive disorders
Gómez-Wong et al. Effects of a prepulse stimulus on the masseteric inhibitory reflex in humans
HUP9701606A2 (hu) Szulbutiamin alkalmazása bizonyos pszichomotoros és pszichointellektuális rendellenességek kezelésére használható gyógyszerkészítmények előállítására
Menon et al. Sertraline and liver toxicity in the elderly.
Jones Psychology for physically disabled people.
Dilley et al. Psychological complications of AIDS.
Dawe et al. Effects of a xanthine derivative, oxpentifylline, on certain psychological parameters of behaviour and performance
MY118760A (en) Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae of cyanobacteria
PE37498A1 (es) Composiciones para la prevencion y tratamiento de trastornos gastrointestinales
Ratanova EMOTIONAL ASSESSMENT OF AUDITORY-STIMULI OF DIFFERENT INTENSITY
Manthorpe Holding hands and resolving grief.
MY113635A (en) Methods and compositions for the prevention and treatment of gastrointestinal disorders
Gambini et al. Neurofunctional assessment of functional CNS disorders: Neuropsychological characteristics of hemispheric functioning as related to drug treatment in schizophrenia.
Wedding Screening for cognitive dysfunction in behavior therapy practice.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee